These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6514699)

  • 1. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa; Manzhikova SR
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin].
    Reĭle EE; Polushkina EE
    Probl Tuberk; 1987; (2):22-5. PubMed ID: 3575271
    [No Abstract]   [Full Text] [Related]  

  • 3. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
    Roslik SM; Pashkov IuN; Gerasimova TG; Marveeva SL
    Probl Tuberk; 1990; (5):75-6. PubMed ID: 2388900
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN; Vorob'ev VS; Khoron'ko VV; Anisimova NB; Chubarian VT
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
    German AK; Syrovatka IuA; Bondarenko VP
    Vrach Delo; 1985 Oct; (10):98-100. PubMed ID: 4090447
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 8. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
    Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA
    Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES; Abrarov BA
    Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
    Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 13. [The inactivation of glucocorticosteroid hormones by rifampicin when it is used intermittently].
    Basov PV; Prokhorov NN; Spesivtsev OG
    Vrach Delo; 1990 Nov; (11):20-2. PubMed ID: 2098973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inactivation of glucocorticoid hormones by rifampicin in the treatment of patients with pulmonary tuberculosis].
    Spesivtsev OG; Basov PV
    Probl Tuberk; 1988; (12):27-8. PubMed ID: 3244680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 18. [Qualitative reaction for determining rifampicin in the urine for the purpose of controlling patient intake of this preparation].
    Tatarinova NV; Zhuk NA; Chukanov VI
    Probl Tuberk; 1979 Aug; (8):62-5. PubMed ID: 482271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complex chemotherapy of pulmonary tuberculosis in adolescents using rifampicin and levamisole].
    Ganiev KG
    Probl Tuberk; 1985; (1):47-50. PubMed ID: 3983116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.